Abstract Number: 774 • 2015 ACR/ARHP Annual Meeting
Anti-Nuclear Antibodies Have High Sensitivity for Systemic Lupus Erythematosus: Results of a Systematic Literature Review and Meta-Regression of Diagnostic Data
Background/Purpose: EULAR and ACR have jointly funded a project to improve existing SLE classification criteria, aiming at earlier and more accurate classification of the disease.…Abstract Number: 775 • 2015 ACR/ARHP Annual Meeting
Identification of Candidate Items for Revised Classification Criteria for Systemic Lupus Erythematosus
Background/Purpose: EULAR and ACR have jointly funded a project to improve existing classification criteria for SLE; this abstract reports on the early phase of this…Abstract Number: 776 • 2015 ACR/ARHP Annual Meeting
Sensitivity of Antinuclear Antibody By Immunofluorescence Testing for Detection of Anti-Ro/SSA Antibodies
Background/Purpose: A positive ANA test is a diagnostic criterion for several rheumatic diseases, although it may appear in other autoimmune disorders and healthy individuals. An…Abstract Number: 777 • 2015 ACR/ARHP Annual Meeting
SLE-KeyTM Rule-out Test to Assess Lupus in Anti-Nuclear Antibody Positive Subjects Using the Immunarray iCHIP®
Background/Purpose: SLE is associated with a broad spectrum of autoantibodies, but currently there is no single serologic test to diagnose SLE definitively. Diagnosis is thus…Abstract Number: 778 • 2015 ACR/ARHP Annual Meeting
Associations Between Autoantibodies and Clinical Manifestations in Systemic Lupus Erythematosus: Data from a Multiethnic Latin American Cohort
Background/Purpose: Analyses of the association between autoantibodies and SLE clinical manifestations using cluster analyses assume that centroid and within-cluster residuals are similar inside the cluster…Abstract Number: 779 • 2015 ACR/ARHP Annual Meeting
Mapping Perceptions of Medication Decision Making Facilitators: The Importance of Patient Context
Background/Purpose: Our objective was to derive a cognitive map of how stakeholders perceive patient-identified facilitators to establish a theoretical framework for the purpose of developing…Abstract Number: 780 • 2015 ACR/ARHP Annual Meeting
Long-Term Prognosis and Factors Associated with Damage Accrual in Japanese Patients with Systemic Lupus Erythematosus
Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by fluctuating disease activity over periods of years. The estimated 5-year survival rate of…Abstract Number: 781 • 2015 ACR/ARHP Annual Meeting
Anti-Nucleosome Antibodies Versus Anti-DNA Antibodies in the Diagnosis and Monitoring of Activity of Systemic Lupus Erytematosus
Background/Purpose: Recently, the study of anti-nucleosome antibodies (ANUCs) has been suggested that they may be useful in the diagnosis of systemic lupus erythematosus (SLE) and in…Abstract Number: 782 • 2015 ACR/ARHP Annual Meeting
A Proposal for Assessing Systemic Lupus Erythematosus Activity By a Multimodal Instrument That Includes Clinical Variables, Physician Assessment and Modification of Treatment
Background/Purpose: Assessment of systemic lupus erythematosus (SLE) is complex due to its heterogeneous manifestations and its fluctuant clinical course. Current instruments stressed one specific aspect…Abstract Number: 783 • 2015 ACR/ARHP Annual Meeting
Osteonecrosis in Systemic Lupus Erythematosus: Predictive Factors
Background/Purpose: We recently reported the frequency of symptomatic osteonecrosis (ON) among systemic lupus erythematosus (SLE) patients of the lupus cohort to be 13.6% The aim…Abstract Number: 784 • 2015 ACR/ARHP Annual Meeting
Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts
Background/Purpose: Enhancing a typical EHR through implementation and utilization of research-validated instruments is termed Electronic Data Capture (EDC). EDC is found to be more efficient…Abstract Number: 785 • 2015 ACR/ARHP Annual Meeting
Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE
Background/Purpose: An easy, quick tool, requiring minimal training or physician input for disease activity (DA) assessment in SLE, would have potentially greater uptake for routine…Abstract Number: 786 • 2015 ACR/ARHP Annual Meeting
Anti-Carbamylated Protein Antibodies Identify Systemic Lupus Erythematosus Patients with Erosive Arthritis: Analysis of a Regional Swedish Register
Background/Purpose: Articular manifestations affect a majority of patients with systemic lupus erythematosus (SLE), at least at some time during the disease course. Several investigators have…Abstract Number: 787 • 2015 ACR/ARHP Annual Meeting
Validation of Lupuspro V1.8, Disease Targeted Patient Reported Outcome for Systemic Lupus Erythematosus
Background/Purpose: Disease Specific Patient reported outcome measure tools capture unique domains relevant to patients with a specific disease. LupusPRO is targeted towards measuring health (HRQOL)…Abstract Number: 788 • 2015 ACR/ARHP Annual Meeting
Identification of Molecular Biomarkers to Distinguish Systemic Lupus Erythematosus with Skin Involvement from Discoid Lupus Erythematosus and Subacute Cutaneous Erythematosus: Provisional Results from Cross-Sectional Studies
Background/Purpose: Sub-classification of Lupus Erythematosus (LE) patients is largely based on defined clinical criteria while biological factors associating with or contributing to these clinical features…
ACR Meeting Abstracts